News

News

08

2016-08

BrosMed Announces FDA 510(k) Clearance and Launch of Additional Configurations of Apollo™ NC PTCA Balloon Catheters in the United States and North America Market

BrosMed Announces FDA 510(k) Clearance and Launch of Additional Configurations of Apollo™ NC PTCA Balloon Catheters in the United States and North America Market

2016-08-08

13

2016-03

BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire

BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire

2016-03-13

01

2015-08

BrosMed Enters the USA Coronary Angioplasty Catheter Market

BrosMed Enters the USA Coronary Angioplasty Catheter Market August 1st, 2015—BrosMed announced that BrosMed Medical and US Endovascular entered into an exclusive agreement to distribute coronary angioplasty catheters in the USA market.

2015-08-01

14

2015-04

BrosMed Announces CE Mark and Launch for Minerva™ Balloon Dilatation Catheter

April 14, 2015—BrosMed announced the CE Mark and launch of its Minerva™ percutaneous transluminal angioplasty (PTA) dilatation catheter for the treatment of patients with peripheral arterial disease.

2015-04-14

27

2014-12

BrosMed Management Team Held a Meeting with the Member of the Dutch Parliament and Vice Minister of Health–Mr.Bas van’t Wout

On December 16th, 2014, Mr. Benny Lee, GM of BrosMed Medical, and Mr. Stephen Lee, Deputy GM of BrosMed Medical, held an effective and productive meeting with Mr. Bas van’t Wout, Member of the Dutch Parliament and Vice Minister of Health, accompanied by Mr. Jos de Korte, GM of BrosMed B.V.

2014-12-27

08

2014-10

BrosMed Announces FDA 510(k) Clearance and Launch for Apollo™ Balloon Dilatation Catheter in the North America and Global Market

October 8, 2014— Following the FDA approval of Artimes™ Balloon Dilatation Catheter in September, BrosMed announced FDA 510(k) clearance for Apollo™ Balloon Dilatation Catheter which is now approved and ready for sale in the United States of America and the North American market for the interventional cardiovascular use.

2014-10-08

17

2014-09

BrosMed Announces FDA 510(k) Clearance and Launch for Artimes™ Balloon Dilatation Catheter in North America and Global Market

September 17, 2014— Following the CE approval and launch Artimes™ Balloon Dilatation Catheter, BrosMed announced FDA 510(k) clearance for Artimes™ Balloon Dilatation Catheter which is now approved and ready for sale in the United States of America and the North America market for the interventional cardiovascular use.

2014-09-17

02

2014-09

BrosMed Establishes Europe Subsidiary in the Netherlands

September 2, 2014, BrosMed Medical has announced the establishment of a subsidiary company in the Netherlands, BrosMed Medical B.V.

2014-09-02

< 1...789...18 >
All
  • All
  • Product Management
  • News
  • Introduction
  • Enterprise outlets
  • FAQ
  • Enterprise Video
  • Enterprise Atlas